Job Description
Position Summary
Vertex is seeking a highly experienced and strategic leader to join our team as the Senior Director, Global Commercial Strategy – Type 1 Diabetes (T1D).
In this role, you will be responsible for developing and executing the global commercial strategy for our T1D portfolio. You will work cross-functionally and with external stakeholders to ensure the successful commercialization of innovative therapies that address the unmet needs of patients with T1D.
This is a high-impact role that requires a strong background in global strategic marketing, US market experience, expertise in market development for breakthrough therapies, and the ability to drive strategic initiatives in a fast-paced, dynamic environment.
Key Responsibilities
- Develop and lead the global commercial strategy for Vertex’s T1D portfolio, ensuring alignment with corporate objectives and market needs.
- Conduct in-depth market analysis to identify opportunities, challenges, and trends in the T1D therapeutic area.
- Collaborate with cross-functional teams, including R&D, medical affairs, regulatory, and market access, to ensure seamless integration of commercial strategies.
- Drive the development of launch plans, including market segmentation, positioning, pricing, and promotional strategies.
- Build and maintain strong relationships with key external stakeholders, including healthcare professionals, patient advocacy groups, and industry partners.
- Provide strategic guidance to regional and local commercial teams to ensure successful execution of global strategies, with a particular focus on the US market.
- Monitor and evaluate the performance of the T1D portfolio, providing insights and recommendations for continuous improvement.
- Represent the commercial perspective in internal decision-making forums and provide input into clinical development plans.
- Lead and mentor a high-performing team, fostering a culture of collaboration, innovation, and excellence.
Qualifications
Education and Experience
- Bachelor’s degree in Business, Life Sciences, or a related field; MBA or advanced degree preferred.
- Minimum of 12 years of experience in the biotechnology, pharmaceutical, or healthcare industry, with at least 5 years in a leadership role.
- Proven track record of developing and executing successful global commercial strategies, especially in endocrinology or immunology.
- Experience in a global strategic marketing function, with a demonstrated ability to develop and implement strategies across multiple geographies.
- Direct experience in the US market, including a strong understanding of its unique dynamics, stakeholders, and regulatory environment.
Skills and Competencies
- Strong experience in market development for breakthrough therapies, with a focus on innovative and patient-centered approaches.
- Strong strategic thinking and analytical skills, with the ability to synthesize complex information and make data-driven decisions.
- Excellent leadership and team management skills, with a demonstrated ability to inspire and develop high-performing teams.
- Exceptional communication and interpersonal skills, with the ability to influence and build relationships across all levels of the organization.
- Experience in product launch planning and execution on a global scale.
- Strong business acumen and financial modeling skills.
- Ability to thrive in a fast-paced, dynamic environment and manage multiple priorities effectively.
Pay Range:
$228,000 - $342,000Disclosure Statement:
The range provided is based on what we believe is a reasonable estimate for the base salary pay range for this job at the time of posting. This role is eligible for an annual bonus and annual equity awards. Some roles may also be eligible for overtime pay, in accordance with federal and state requirements. Actual base salary pay will be based on a number of factors, including skills, competencies, experience, and other job-related factors permitted by law.
At Vertex, our Total Rewards offerings also include inclusive market-leading benefits to meet our employees wherever they are in their career, financial, family and wellbeing journey while providing flexibility and resources to support their growth and aspirations. From medical, dental and vision benefits to generous paid time off (including a week-long company shutdown in the Summer and the Winter), educational assistance programs including student loan repayment, a generous commuting subsidy, matching charitable donations, 401(k) and so much more.
Flex Designation:
Hybrid-Eligible Or On-Site EligibleFlex Eligibility Status:
In this Hybrid-Eligible role, you can choose to be designated as:
1. Hybrid: work remotely up to two days per week; or select
2. On-Site: work five days per week on-site with ad hoc flexibility.
Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time.
#LI-Hybrid
Company Information
Vertex is a global biotechnology company that invests in scientific innovation.
Vertex is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, sexual orientation, marital status, or any characteristic protected under applicable law. Vertex is an E-Verify Employer in the United States. Vertex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Any applicant requiring an accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should make a request to the recruiter or hiring manager, or contact Talent Acquisition at [email protected]
Vertex Pharmaceuticals Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Vertex Pharmaceuticals and has not been reviewed or approved by Vertex Pharmaceuticals.
-
Parental & Family Support — Policies provide 12 weeks of 100% paid bonding leave for all U.S. parents with additional fully paid time for birth parents. Family-forming supports include adoption and surrogacy assistance, fertility options like IVF and egg cryopreservation, breast‑milk shipping, subsidized childcare, backup care, and a DCFSA match.
-
Leave & Time Off Breadth — Time off includes roughly four weeks of vacation, 13 holidays, sick time, and two companywide shutdowns (summer and year‑end). Some roles also include flexible or unlimited time off and paid volunteer time.
-
Retirement Support — Programs include a 401(k) plan with employer contributions and an employee stock purchase plan. Filings describe employer contributions occurring in company stock, supporting long‑term ownership.
Vertex Pharmaceuticals Insights
Similar Jobs
What We Do
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. We discovered and developed the first medicines to treat the underlying cause of cystic fibrosis (CF), a rare, life-threatening genetic disease. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases. Founded in 1989 in Cambridge, Massachusetts, our corporate headquarters is now located in Boston’s Innovation District, and our international headquarters is in London, United Kingdom. We currently employ approximately 3,500 people in the United States, Europe, Canada, Australia and Latin America with nearly two-thirds of our staff dedicated to research and development. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. Our research and medicines have also received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the French Prix Galien and the British Pharmacological Society awards.
